Terms were not disclosed, but North Castle Partners has brought in Nature's Way owner, Schwabe Pharmaceuticals, to buy the outstanding shares of Enzymatic Therapy.
Terms of the deal were not disclosed, but NBJ pegs Nature's Way sales in the $130-150 million range and Enzymatic Therapy sales in the $100-130 million range. The combination of Nature's Way and Enzymatic Therapy creates a major force in the high-end supplement sector, and a new leader in the natural retail channel. Many have wondered if Enzymatic Therapy has thrived under ownership by North Castle Partners who may have found the perfect partner in Nature's Way/Schwabe - a leader in the category and channel with access to foreign currency.
Lincoln International, a leading mid-market investment bank, acted as the exclusive financial advisor to Schwabe and Nature's Way on the deal.
The press release noted, "Initial focus will be to further advance product development in bringing highly effective natural health solutions to market to elevate wellness for those critical health concerns of consumers."
Dr. Dirk Reischig, Chairman and CEO of Schwabe: "We are very delighted that Enzymatic Therapy, Inc. joins the Schwabe group of companies. We do believe that the complementary product portfolios and marketing know-how of Enzymatic Therapy and Nature's Way will significantly strengthen our presence in the US market, which is one of Schwabe's strategic key markets for future growth. Natural health care solutions will become increasingly important over the next few decades. The joined forces of Enzymatic Therapy, Nature's Way and Schwabe will therefore contribute significantly to consumers in the USA and abroad in achieving the best possible health and quality of life."
Rory Mahony, CEO of Nature's Way: "We look forward to leveraging the knowledge and expertise resident in our companies and to further enhance the significant business growth that both Nature's Way and Enzymatic Therapy have enjoyed over the past several years. We believe the dedication of the companies to the development of quality products will benefit our customers in many ways."
Randy Rose, CEO of ETI: "We are very pleased to align with Nature's Way and Dr. Willmar Schwabe Pharmaceuticals in elevating the health and well being of consumers and patients by combining the very best know how of each of the companies. The highly ethical approach to delivering true natural medicines that improve lives is a consistent core value for all three entities and we look forward to advancing the natural health care solutions for the benefit of all."
More to come soon.